We turn menstrual blood into a scalable, non-invasive biopsy, generating proprietary data to power patient stratification, smarter clinical trials and drug discovery.
190 million women worldwide suffer from endometriosis, yet diagnosis still takes 10 years on average, and curative treatments remain unavailable.
A fundamental challenge is the lack of high-quality human uterine data. Accessing this biology typically requires invasive surgery, while existing animal models fail to capture the complexity of human disease.
As a result, uterine diseases remain poorly characterized at the molecular level.
By combining menstrual blood, advanced wet-lab profiling, and computational modeling, Endoprofile™ unlocks a previously inaccessible layer of human biology, generating the data needed to better understand disease mechanisms, stratify patients, and accelerate therapeutic discovery in uterine health.
Most human uterine biology remains inaccessible. Endoprofile™ combines biological access, molecular profiling, and computational modeling to generate the data needed to understand disease biology.
We've built the first scalable, non-invasive window into the uterus, enabling access to disease-relevant biology through menstrual blood.
We build predictive models from biological data, mapping disease initiation, progression and therapeutic response at the molecular level.
We translate our unique biological insights into clinical and therapeutic outcomes, improving patient diagnosis, stratification, and treatment.
We are a multidisciplinary team of scientists and operators building the biological data platform for uterine health.
Combining expertise in uterine health, molecular biology, immunology, bioinformatics and oncology, we generate and model high-resolution data to improve drug discovery.
Our team brings experience from leading research institutions and publications in top-tier journals.
Scientific rigor
Biological insight
Data-driven thinking
We generate and publish new biological insights through peer-reviewed research and scientific collaborations.
Peer-reviewed publications
Latest news
Partner with endogene.bio to access novel biological insights, proprietary datasets, and translational research opportunities in uterine health.
Who we work with
We partner with biopharma teams to de-risk clinical development, identify novel therapeutic targets and enable indication expansion through proprietary uterine health datasets.
We collaborate with clinical centers on patient recruitment, molecular profiling, and translational research programs in uterine health.
We collaborate with researchers to generate novel biological insights and advance the science of uterine health.
